Čájehuvvojit 1 - 3 oktiibuot 3 bohtosis ohcui Vetter M', ohcanáigi: 0,02s
Aiddostahte ozu
-
1
Strategy for data modelling : application and enterprise-wide / Dahkki 401019 Vetter, M.
Almmustuhtton 1987 -
2
-
3
Effects of vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases Dahkki Lynch, K, Chapman, R, Keshav, S, Montano-Loza, A, Mason, A, Kremer, A, Vetter, M, De Krijger, M, Ponsioen, C, Trivedi, P, Hirschfield, G, Schramm, C, Liu, C, Bowlus, C, Estes, D, Pratt, D, Hedin, C, Bergquist, A, De Vries, A, Janneke Van Der Woude, C, Yu, L, Assis, D, Boyer, J, Ytting, H, Hallibasic, E, Trauner, M, Marschall, H, Daretti, L, Marzioni, M, Yimam, K, Perin, N, Floreani, A, Beretta-Piccoli, B, Rogers, J, International Primary Sclerosing Cholangitis Study Group (IPSCSG), Levy, C
Almmustuhtton 2019Journal article